Brian McClune, DO
Assistant Professor of Medicine
Hematologist / Oncologist
- Blood Cancer
- Blood and Marrow Transplantation
- Blood and Marrow Transplant
- Masonic Cancer Clinic
Kansas City University of Medicine and Biosciences, College of Osteopathic Medicine
Johns Hopkins University School of Medicine (Internal Medicine)
University of Tennessee Health Science Center (Hematology/Oncology)
E: Stacy Maher
P: (612) 626-0400
F: (612) 625-6919
Division of Hematology, Oncology and Transplantation
420 Delaware Street SE, MMC 480
Minneapolis, MN 55455
Dr. McClune is an Assistant Professor in the Division of Hematology, Oncology and Transplantation joining as faculty in September 2006. He completed his DO degree at the Kansas City University of Medicine and Biosciences, College of Osteopathic Medicine in 2000. After finishing an Internal Medicine residency at the Johns Hopkins University School of Medicine in 2003, he went on to complete a Hematology/Oncology Fellowship at the University of Tennessee Health Science Center in 2006 with an emphasis in Hematopoietic Stem Cell Transplantation, having served as Chief Fellow his last year. He is currently serving as the Fellowship Program Director.
Dr. McClune’s clinical interest is in the treatment of hematological malignancies using stem cell transplantation. He has particular interest in transplantation for myeloma, long-term effects of transplantation, and in advancing supportive care approaches for patients undergoing the process.
- Fellowship Program Director
- Member, American Society of Hematology
- Member, American Society of Clinical Oncology
- Member, American Society of Blood and Marrow Transplantation
- Johns Hopkins University/Sinai Hospital Excellence in Outpatient Medicine Award (2002-2003)
- Johns Hopkins University/Sinai Hospital Medicine Resident Award for Excellence in Humanism and Professionalism (2001-2002)
- McClune B, Majhail NS, Flowers ME. Bone loss and avascular necrosis of bone after hematopoietic cell transplantation. Semin Hematol. 2012;49(1):59-65.
- McClune BL, Defor T, Brunstein C et al. Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting. Br J Haematol. 2012 Jan;156(2):273-5.
- McClune B and Weisdorf D. Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care? Curr Opin Hematol. 2010;17(2):133-8.
- McClune B, Buadi FK, Aslam N, Przepiorka D. Intrathecal Liposomal Cytarabine For Prevention of Meningeal Disease In Patients With Acute Lymphocytic Leukemia and High-Grade Lymphoma. Leukemia and Lymphoma. 2007;48(9):1849 – 1851.